NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse model of Huntington disease-Reference-Cited by-同舟云学术

NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse model of Huntington disease

Published:2012-12 Issue:3 Volume:48 Page:282-289
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Pouladi Mahmoud A.,Brillaud Elsa,Xie Yuanyun,Conforti Paola,Graham Rona K.,Ehrnhoefer Dagmar E.,Franciosi Sonia,Zhang Weining,Poucheret Patrick,Compte Elsa,Maurel Jean-Claude,Zuccato Chiara,Cattaneo Elena,Néri Christian,Hayden Michael R.

Funder

Medesis Pharma

BC Innovation Council Ripples of Hope Award in Biotechnology & Entrepreneurship

Canadian Institute of Health Research and the Michael Smith Foundation for Health Research (MSFHR)

CIHR

Huntington Society of Canada

Huntington's Disease Society of America

CHDI Foundation

ANR

AP-HP

Publisher

Elsevier BV

Subject

Neurology

Reference45 articles.

1. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death;Arrasate;Nature,2004

2. Huntington's disease;Bates,2002

3. Lithium rescues toxicity of aggregate-prone proteins in Drosophila by perturbing Wnt pathway;Berger;Hum. Mol. Genet.,2005

4. Glycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation;Carmichael;J. Biol. Chem.,2002

5. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons;Chalecka-Franaszek;Proc. Natl. Acad. Sci. U. S. A.,1999

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview;Pharmacological Reviews;2024-02-08

2. Nanolithium, a New Treatment Approach to Alzheimer’s Disease: A Review of Existing Evidence and Clinical Perspectives;The Journal of Prevention of Alzheimer's Disease;2024

3. New insights into glycogen synthase kinase-3: A common target for neurodegenerative diseases;Biochemical Pharmacology;2023-12

4. The Neurobiological Role of Lithium Salts;Neuroscience and Behavioral Physiology;2023-07

5. Implications of Tau Dysregulation in Huntington’s Disease and Potential for New Therapeutics;Journal of Huntington's Disease;2023-05-02